Thyrocare Technologies Hits New 52-Week High of Rs. 1542.9

Thyrocare Technologies has reached a significant milestone by hitting a new 52-week high of Rs. 1542.9 on November 13, 2025. This achievement marks a notable performance for the small-cap healthcare services company, which has outperformed its sector by 6.76% today. The stock has shown consistent upward momentum, gaining for three consecutive days and delivering a total return of 10.43% during this period.
In terms of technical performance, Thyrocare Technologies is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend. Over the past year, the stock has delivered impressive returns of 59.91%, significantly outpacing the Sensex, which has risen by 9.09% in the same timeframe.

The company has also reported robust financial metrics, including a high return on equity (ROE) of 23.66% and a low debt-to-equity ratio, reflecting strong management efficiency. With a net profit growth of 77.95% reported in its latest quarterly results, Thyrocare Technologies continues to demonstrate solid performance in the healthcare sector.